A new trading day began on Tuesday, with Pliant Therapeutics Inc (NASDAQ: PLRX) stock price up 4.00% from the previous day of trading, before settling in for the closing price of $1.25. PLRX’s price has ranged from $1.10 to $16.10 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -78.30% over the last five years. Meanwhile, its annual earnings per share averaged 28.78%. With a float of $54.04 million, this company’s outstanding shares have now reached $61.39 million.
The firm has a total of 171 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Pliant Therapeutics Inc (PLRX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Pliant Therapeutics Inc is 11.97%, while institutional ownership is 86.96%. The most recent insider transaction that took place on Jan 17 ’25, was worth 587,150. In this transaction President and CEO of this company sold 52,419 shares at a rate of $11.20, taking the stock ownership to the 430,517 shares. Before that another transaction happened on Jan 17 ’25, when Company’s Chief Financial Officer sold 20,148 for $11.20, making the entire transaction worth $225,680. This insider now owns 262,608 shares in total.
Pliant Therapeutics Inc (PLRX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 28.78% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.14% during the next five years compared to -78.30% drop over the previous five years of trading.
Pliant Therapeutics Inc (NASDAQ: PLRX) Trading Performance Indicators
Here are Pliant Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 11.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.61, a number that is poised to hit -0.66 in the next quarter and is forecasted to reach -1.91 in one year’s time.
Technical Analysis of Pliant Therapeutics Inc (PLRX)
Analysing the last 5-days average volume posted by the [Pliant Therapeutics Inc, PLRX], we can find that recorded value of 0.77 million was lower than the volume posted last year of 1.82 million. As of the previous 9 days, the stock’s Stochastic %D was 10.86%.
During the past 100 days, Pliant Therapeutics Inc’s (PLRX) raw stochastic average was set at 1.70%, which indicates a significant decrease from 15.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 46.12% in the past 14 days, which was lower than the 230.17% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4406, while its 200-day Moving Average is $7.6904. Now, the first resistance to watch is $1.3400. This is followed by the second major resistance level at $1.3800. The third major resistance level sits at $1.4300. If the price goes on to break the first support level at $1.2500, it is likely to go to the next support level at $1.2000. Should the price break the second support level, the third support level stands at $1.1600.
Pliant Therapeutics Inc (NASDAQ: PLRX) Key Stats
With a market capitalization of 79.80 million, the company has a total of 61,386K Shares Outstanding. Currently, annual sales are 0 K while annual income is -210,300 K. The company’s previous quarter sales were 0 K while its latest quarter income was -56,170 K.
